Spots Global Cancer Trial Database for flow cytometry
Every month we try and update this database with for flow cytometry cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia | NCT03803670 | Acute Lymphobla... | evaluation of c... | - | University of Rome Tor Vergata | |
| Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation | NCT00052520 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... B-cell Adult Ac... B-cell Childhoo... Childhood Chron... Childhood Myelo... Chronic Myelomo... Essential Throm... Polycythemia Ve... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Acute... T-cell Adult Ac... T-cell Childhoo... | therapeutic all... aldesleukin peripheral bloo... allogeneic bone... laboratory biom... gene expression... immunologic tec... flow cytometry polymerase chai... cytogenetic ana... staining method | - | Fred Hutchinson Cancer Center | |
| Biomarkers in Samples From Young Patients With Neuroblastoma | NCT01358604 | Neuroblastoma | polymerase chai... protein express... western blottin... flow cytometry immunohistochem... laboratory biom... | - 120 Years | Children's Oncology Group | |
| Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study. | NCT04882475 | Mantle Cell Lym... | 18 Years - 80 Years | Fondazione Italiana Linfomi - ETS | ||
| Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer | NCT00546377 | Leukemia Lymphoma | filgrastim pegfilgrastim rituximab sargramostim cyclophosphamid... mitoxantrone hy... pentostatin fluorescence in... gene rearrangem... polymerase chai... protein express... flow cytometry biopsy | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer | NCT01058785 | Lung Neoplasm Carcinoma, Bron... | Lucanix | 18 Years - | NovaRx Corporation | |
| AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors | NCT00372736 | Unspecified Adu... | AEG35156 docetaxel protein express... reverse transcr... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | Canadian Cancer Trials Group | |
| Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome | NCT00445744 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Childhood Acute... Childhood Myelo... de Novo Myelody... Essential Throm... Myelodysplastic... Polycythemia Ve... Previously Trea... Primary Myelofi... Recurrent Adult... Recurrent Child... Secondary Acute... Secondary Myelo... Secondary Myelo... Untreated Adult... Untreated Child... | cyclophosphamid... busulfan tacrolimus methotrexate cytogenetic ana... flow cytometry pharmacological... pharmacogenomic... peripheral bloo... allogeneic hema... | - 65 Years | Fred Hutchinson Cancer Center | |
| Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 | NCT00896701 | Leukemia | flow cytometry immunologic tec... laboratory biom... | 15 Years - | Alliance for Clinical Trials in Oncology | |
| Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | NCT00524186 | Esophageal Canc... Gastric Cancer | fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... flow cytometry pharmacological... | - 120 Years | Roswell Park Cancer Institute | |
| Intraoperative Flow Cytometry In Colorectal Cancer | NCT05261542 | Colorectal Canc... | flow cytometry | 25 Years - 90 Years | University Hospital, Ioannina | |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma | NCT00398138 | Leukemia Lung Cancer Malignant Mesot... Myelodysplastic... Primary Periton... | WT-1 analog pep... incomplete Freu... sargramostim polymerase chai... flow cytometry immunoenzyme te... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer | NCT00373022 | Anxiety Disorde... Colorectal Canc... Depression Psychosocial Ef... | exercise interv... flow cytometry laboratory biom... management of t... psychosocial as... quality-of-life... | 18 Years - | University of Arizona | |
| Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome | NCT00003790 | Leukemia Myelodysplastic... | polymerase chai... flow cytometry | - 21 Years | Children's Oncology Group | |
| Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer | NCT00482872 | Head and Neck C... | gene expression... mutation analys... polymerase chai... polymorphism an... flow cytometry laboratory biom... | 18 Years - 120 Years | Vanderbilt University Medical Center | |
| Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer | NCT00689975 | Breast Cancer | behavioral diet... exercise interv... counseling inte... flow cytometry immunoenzyme te... laboratory biom... complementary o... standard follow... | - | National Cancer Institute (NCI) | |
| Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | NCT00453050 | Melanoma (Skin) Metastatic Canc... | imiquimod indocyanine gre... flow cytometry immunologic tec... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia | NCT01338974 | Leukemia | gene expression... proteomic profi... flow cytometry laboratory biom... | 56 Years - | SWOG Cancer Research Network | |
| Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma | NCT01165645 | Hodgkin Lymphom... Stage I Adult H... Stage II Adult ... Stage III Adult... Stage IV Adult ... | lopinavir ritonavir polymerase chai... flow cytometry enzyme-linked i... laboratory biom... | 18 Years - | Mayo Clinic | |
| Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA) | NCT05746858 | Diffuse Large B... Relapsed Non-Ho... | no intervention... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma | NCT00398138 | Leukemia Lung Cancer Malignant Mesot... Myelodysplastic... Primary Periton... | WT-1 analog pep... incomplete Freu... sargramostim polymerase chai... flow cytometry immunoenzyme te... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery | NCT00652860 | Metastatic Canc... Sarcoma | aerosol sargram... sargramostim cisplatin doxorubicin hyd... ifosfamide mitomycin C flow cytometry immunological d... laboratory biom... adjuvant therap... multimodality t... neoadjuvant the... therapeutic con... intraoperative ... selective exter... | 18 Years - | Mayo Clinic | |
| Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma | NCT00567229 | Multiple Myelom... | rituximab lenalidomide microarray anal... flow cytometry laboratory biom... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow | NCT00824538 | Breast Cancer | sunitinib malat... flow cytometry immunohistochem... laboratory biom... | 18 Years - 120 Years | University of California, San Francisco | |
| Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr) | NCT05419648 | Myeloproliferat... | 1 additional tu... | 18 Years - | University Hospital, Bordeaux | |
| Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | NCT00453050 | Melanoma (Skin) Metastatic Canc... | imiquimod indocyanine gre... flow cytometry immunologic tec... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia | NCT00005619 | Leukemia | polymerase chai... flow cytometry immunohistochem... | 18 Years - | Northwestern University | |
| Talabostat in Treating Patients With Metastatic Kidney Cancer | NCT00489710 | Kidney Cancer | talabostat mesy... enzyme inhibito... flow cytometry laboratory biom... non-specific im... | 19 Years - 120 Years | University of Nebraska | |
| Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy | NCT01169363 | Leukemia | proteomic profi... flow cytometry laboratory biom... | 60 Years - 120 Years | Eastern Cooperative Oncology Group | |
| SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer | NCT00900042 | Kidney Cancer | DNA ploidy anal... DNA stability a... chromosomal tra... cytogenetic ana... flow cytometry laboratory biom... | - | SWOG Cancer Research Network | |
| EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer | NCT00049140 | Head and Neck C... | EF5 bioluminescence flow cytometry immunohistochem... biopsy | 18 Years - | Duke University | |
| Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome | NCT00445744 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Childhood Acute... Childhood Myelo... de Novo Myelody... Essential Throm... Myelodysplastic... Polycythemia Ve... Previously Trea... Primary Myelofi... Recurrent Adult... Recurrent Child... Secondary Acute... Secondary Myelo... Secondary Myelo... Untreated Adult... Untreated Child... | cyclophosphamid... busulfan tacrolimus methotrexate cytogenetic ana... flow cytometry pharmacological... pharmacogenomic... peripheral bloo... allogeneic hema... | - 65 Years | Fred Hutchinson Cancer Center | |
| Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma | NCT00553306 | Recurrent Melan... Stage IV Melano... | therapeutic aut... aldesleukin cyclophosphamid... biopsy immunohistochem... flow cytometry polymerase chai... | 18 Years - 75 Years | Fred Hutchinson Cancer Center | |
| Intraoperative Flow Cytometry In Colorectal Cancer | NCT05261542 | Colorectal Canc... | flow cytometry | 25 Years - 90 Years | University Hospital, Ioannina | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma | NCT00061048 | Acute T-Cell Le... | Alemtuzumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia | NCT01649791 | B-cell Chronic ... Chronic Lymphoc... Stage 0 Chronic... Stage I Chronic... Stage II Chroni... | lenalidomide laboratory biom... lymph node biop... bone marrow asp... pharmacological... flow cytometry | 18 Years - | Roswell Park Cancer Institute | |
| Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | NCT00388089 | Lung Cancer Unspecified Adu... | bortezomib topotecan hydro... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | University of California, Davis | |
| Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma | NCT00958074 | Cutaneous T-cel... Cutaneous T-cel... Cutaneous T-cel... Cutaneous T-cel... | vorinostat flow cytometry laboratory biom... | 18 Years - | University of Washington | |
| Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma | NCT00658892 | Melanoma (Skin) | B7-DC cross-lin... flow cytometry immunologic tec... laboratory biom... | 18 Years - 120 Years | Mayo Clinic | |
| Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma | NCT01045928 | Adult Non-Hodgk... Adult Grade III... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Cutaneous B-cel... Extranodal Marg... Nodal Marginal ... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Splenic Margina... Stage I Adult B... Stage I Adult D... Stage I Adult D... Stage I Adult D... Stage I Adult I... Stage I Adult L... Stage I Grade 1... Stage I Grade 2... Stage I Grade 3... Stage I Mantle ... Stage I Margina... Stage I Small L... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Grade... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Waldenstrom Mac... | lenalidomide rituximab polymerase chai... nucleic acid se... polymorphism an... flow cytometry laboratory biom... | 18 Years - | Case Comprehensive Cancer Center | |
| Evaluation of ClearLLab Leukemia and Lymphoma Panels | NCT03413644 | Leukemia-Lympho... | Flow Cytometry | - | Beckman Coulter, Inc. | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer | NCT00049140 | Head and Neck C... | EF5 bioluminescence flow cytometry immunohistochem... biopsy | 18 Years - | Duke University | |
| Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 | NCT00896701 | Leukemia | flow cytometry immunologic tec... laboratory biom... | 15 Years - | Alliance for Clinical Trials in Oncology | |
| Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma | NCT00110071 | Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Splenic Margina... Waldenström Mac... | fludarabine pho... peripheral bloo... iodine I 131 to... laboratory biom... flow cytometry polymerase chai... | 60 Years - | Fred Hutchinson Cancer Center | |
| Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery | NCT00524069 | Pancreatic Canc... | bevacizumab capecitabine gemcitabine hyd... flow cytometry laboratory biom... adjuvant therap... computed tomogr... neoadjuvant the... | 18 Years - | Roswell Park Cancer Institute | |
| EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | NCT00041028 | Lung Cancer | EF5 flow cytometry immunohistochem... | 18 Years - | National Cancer Institute (NCI) | |
| Evaluation of ClearLLab Leukemia and Lymphoma Panels | NCT03413644 | Leukemia-Lympho... | Flow Cytometry | - | Beckman Coulter, Inc. | |
| Study of Proteins in Head and Neck Cancer Cells | NCT00896948 | Head and Neck C... | Southern blotti... TdT-mediated dU... gene expression... protein express... flow cytometry fluorescent ant... immunoenzyme te... immunohistochem... immunologic tec... | - 120 Years | Vanderbilt University Medical Center | |
| White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors | NCT00709020 | Breast Cancer Cancer Survivor | white button mu... flow cytometry high performanc... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... | 21 Years - | City of Hope Medical Center | |
| FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | NCT01413022 | Pancreatic Neop... | Oxaliplatin Irinotecan Leucovorin Fluorouracil laboratory biom... flow cytometry immunohistochem... pharmacological... PF-04136309 | 18 Years - | Washington University School of Medicine | |
| Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma | NCT00617799 | Kidney Cancer Melanoma (Skin) | aldesleukin gene expression... mutation analys... flow cytometry | 19 Years - 120 Years | University of Nebraska | |
| Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma | NCT00110071 | Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Splenic Margina... Waldenström Mac... | fludarabine pho... peripheral bloo... iodine I 131 to... laboratory biom... flow cytometry polymerase chai... | 60 Years - | Fred Hutchinson Cancer Center | |
| Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases | NCT00450983 | Graft Versus Ho... Leukemia Myelodysplastic... | muromonab-CD3 natural killer ... fludarabine pho... methotrexate thiotepa gene expression... flow cytometry immunologic tec... allogeneic hema... in vitro-treate... total-body irra... | - 45 Years | Fred Hutchinson Cancer Center | |
| Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia | NCT01269385 | B-cell Chronic ... Refractory Chro... Stage 0 Chronic... Stage I Chronic... Stage II Chroni... | alemtuzumab rituximab PGG beta-glucan flow cytometry laboratory biom... DNA analysis fluorescence in... polymerase chai... polymorphism an... mutation analys... | 18 Years - | Mayo Clinic | |
| Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer | NCT00513695 | Inflammatory Br... Male Breast Can... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | sunitinib malat... paclitaxel doxorubicin hyd... cyclophosphamid... filgrastim therapeutic con... laboratory biom... flow cytometry | - | University of Washington | |
| Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant | NCT00898118 | Leukemia Myelodysplastic... | polymerase chai... flow cytometry laboratory biom... allogeneic hema... | - 17 Years | National Cancer Institute (NCI) | |
| PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer | NCT00589550 | Kidney Cancer | PEG-interferon ... Sorafenib gene expression... polymerase chai... reverse transcr... flow cytometry immunoenzyme te... laboratory biom... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer | NCT00482872 | Head and Neck C... | gene expression... mutation analys... polymerase chai... polymorphism an... flow cytometry laboratory biom... | 18 Years - 120 Years | Vanderbilt University Medical Center | |
| Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma | NCT00897910 | Multiple Myelom... | flow cytometry immunoenzyme te... laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer | NCT00897338 | Breast Cancer | flow cytometry fluorescence ac... immunohistochem... immunologic tec... biomarker analy... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma | NCT00621452 | B-cell Chronic ... Extranodal Marg... Nodal Marginal ... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Refractory Chro... Splenic Margina... Waldenström Mac... | therapeutic aut... cyclophosphamid... aldesleukin polymerase chai... gene rearrangem... lymph node biop... genetically eng... bone marrow asp... flow cytometry laboratory biom... enzyme-linked i... | - | Fred Hutchinson Cancer Center | |
| Immune Checkpoint Receptors in AML-Leukemic Initiating Cells | NCT03449745 | Acute Myeloid L... | 18 Years - | University Hospital, Bordeaux | ||
| Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma | NCT01366170 | Lymphoma | microarray anal... protein express... western blottin... flow cytometry immunohistochem... laboratory biom... mass spectromet... | - 20 Years | Children's Oncology Group | |
| Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial | NCT01629745 | Leukemia | gene expression... flow cytometry laboratory biom... | - 30 Years | Children's Oncology Group | |
| Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma | NCT00958074 | Cutaneous T-cel... Cutaneous T-cel... Cutaneous T-cel... Cutaneous T-cel... | vorinostat flow cytometry laboratory biom... | 18 Years - | University of Washington | |
| Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia | NCT01581528 | Leukemia | gene expression... cell culture pr... flow cytometry laboratory biom... metabolic asses... | - | Children's Oncology Group | |
| Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia | NCT01127009 | Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... | bortezomib mitoxantrone hy... etoposide cytarabine flow cytometry | 18 Years - 70 Years | Case Comprehensive Cancer Center | |
| Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997 | NCT00899873 | Leukemia | cytogenetic ana... flow cytometry fluorescence ac... immunoenzyme te... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | NCT00389805 | Lung Cancer Unspecified Adu... | bortezomib pemetrexed diso... gene expression... mutation analys... protein express... reverse transcr... flow cytometry immunoenzyme te... immunohistochem... | 18 Years - 120 Years | University of California, Davis | |
| Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors | NCT00436761 | Unspecified Chi... | anti-thymocyte ... graft-versus-tu... sargramostim busulfan cyclosporine melphalan methylprednisol... flow cytometry immunologic tec... laboratory biom... allogeneic hema... umbilical cord ... | - 21 Years | National Cancer Institute (NCI) | |
| Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer | NCT00514215 | Kidney Cancer Lung Cancer Metastatic Canc... Unspecified Adu... | sargramostim flow cytometry immunoenzyme te... biopsy cryosurgery | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer | NCT00589550 | Kidney Cancer | PEG-interferon ... Sorafenib gene expression... polymerase chai... reverse transcr... flow cytometry immunoenzyme te... laboratory biom... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | NCT00851552 | Lymphoma | rituximab bortezomib pegylated lipos... gene expression... polymerase chai... polymorphism an... proteomic profi... flow cytometry laboratory biom... | 18 Years - | Roswell Park Cancer Institute | |
| Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer | NCT00373022 | Anxiety Disorde... Colorectal Canc... Depression Psychosocial Ef... | exercise interv... flow cytometry laboratory biom... management of t... psychosocial as... quality-of-life... | 18 Years - | University of Arizona | |
| Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia | NCT01251250 | Refractory Chro... Stage II Chroni... Stage III Chron... Stage IV Chroni... | laboratory biom... western blottin... gene expression... pharmacological... flow cytometry fluorescence in... azadirachta ind... reverse transcr... | 18 Years - | Roswell Park Cancer Institute | |
| Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy | NCT00509093 | Leukemia | imatinib mesyla... gene expression... mutation analys... polymerase chai... flow cytometry biopsy | 18 Years - | Case Comprehensive Cancer Center | |
| Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | NCT01328535 | Recurrent Melan... Stage IV Melano... | temozolomide flow cytometry staining method biopsy laboratory biom... | 18 Years - | Mayo Clinic |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
